Arteris CEO linked entity sells 70,000 shares
Arteris, Inc. director, President and CEO K. Charles Janac reported an indirect open-market sale of 70,000 shares of common stock at a weighted average price of $31.1998 per share through Bayview Legacy, LLC.
Rhea-AI Filing Summary
Arteris, Inc. director, President and CEO K. Charles Janac reported an indirect open-market sale of 70,000 shares of common stock at a weighted average price of $31.1998 per share through Bayview Legacy, LLC. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 5, 2025.
Following the sale, Bayview Legacy, LLC held 9,049,071 shares of Arteris common stock. Janac also reported ownership of 196,729 shares held directly and 56,252 shares held indirectly through the Charles and Lydia Janac Trust, for which he serves as trustee.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 70,000 | $31.1998 | $2.18M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (4)
- F1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 5, 2025.
- F2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.19 to $32.07 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The Reporting Person is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Bayview Legacy, LLC.
- F4. The shares are held by Charles and Lydia Janac Trust, for which the Reporting Person serves as trustee.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average sale price financial
voting and dispositive power financial
beneficially owned financial
FAQ
What insider transaction did Arteris (AIP) report for K. Charles Janac?
Was the Arteris (AIP) insider sale by K. Charles Janac pre-planned?
What other Arteris (AIP) holdings does K. Charles Janac report besides Bayview Legacy, LLC?
AI-generated analysis. How Rhea-AI works. Not financial advice.